Ritonavir-boosted atazanavir, methadone, and ventricular tachycardia: 2 Case reports

20Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We describe 2 cases of symptomatic ventricular tachycardia associated with prolonged QT interval. Both patients were infected with the human immunodeficiency virus and were receiving treatment with ritonavir-boosted atazanavir and methadone. Discontinuation of atazanavir in both cases resulted in a reduction in the QT interval and cessation of arrhythmia. We concluded that atazanavir contributed to prolonged corrected QT interval and subsequent ventricular tachycardia. © 2008 by the Infectious Diseases Society of America. All rights reserved.

Cite

CITATION STYLE

APA

Gallagher, D. P., Kieran, J., Sheehan, G., Lambert, J., Mahon, N., & Mallon, P. W. G. (2008). Ritonavir-boosted atazanavir, methadone, and ventricular tachycardia: 2 Case reports. Clinical Infectious Diseases, 47(3). https://doi.org/10.1086/589869

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free